Target intelligence / Profile preview

RNA polymerase II-associated protein 3 (RPAP3)

Target
RPAP3
Molecular classification
Other (co-chaperone, scaffold protein, R2TP complex component)
01

Overview

RNA polymerase II-associated protein 3 (RPAP3) is a human protein that acts as a scaffold and co-chaperone within the R2TP complex, interfacing between RNA polymerase II and the HSP90 chaperone system[1][7]. RPAP3’s structure contains tetratricopeptide repeat (TPR) domains and a C-terminal domain that enable it to recruit and stabilize client proteins—including RNA polymerase II—by facilitating their assembly and proper folding through interactions with RUVBL1, RUVBL2, PIH1D1, and HSP90[1][2][4][5]. It is essential for the biogenesis and cellular stability of several large multi-subunit complexes, particularly RNA polymerase II, and may play broader roles in the assembly of protein complexes involved in transcription, cellular stress response, and potentially apoptosis[6][7]. RPAP3 is not, however, an established therapeutic target in current drug discovery or pharmacology.

Other names
FLJ21908SPAGhSpaghTah1RNA polymerase II associated protein 3RPAP3
02

Biological functions

Assembly and stabilization of RNA polymerase II complexRegulation of transcriptionAssociation with chaperone machinery (HSP90)Regulates or facilitates interactions in multi-protein complexesMay regulate apoptosis
03

Disease associations

Cancer (through transcription regulation or complex formation)Potential associations with Hermansky-Pudlak syndrome 3 and primary ciliary dyskinesia 10 (based on genetic context, not direct targeting)Other (general cellular stress and protein complex assembly)

Beyond the preview

Go deeper on RNA polymerase II-associated protein 3 (RPAP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase II-associated protein 3 (RPAP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call